Abstract
Purpose
To determine the in vivo release profile and retinal safety of cyclosporine A (CsA) delivered from a biodegradable poly-lactide-co-glycolide (PLGA) device in the vitreous cavity of rabbits’ eyes.
Methods
A total of 60 animals (60 eyes) divided into two groups were used. For the in vivo release study, 32 eyes received PLGA implants containing 350 µg of CsA, and 16 eyes received the implants without drug (control). Four animals of CsA group and two of the control group were killed weekly until 8 weeks; the vitreous was removed, and CsA concentration was evaluated. Ophthalmological examination was performed in the animals prior to implant placement and weekly during the study period. Electroretinography (ERG) was performed in other six animals for each group, treated and control, at the beginning and at the end of the study (8 weeks) when they were killed and had their eyes processed for histology.
Results
No sign of inflammation was noticed on slit lamp examinations and the IOP maintained stable during the study period in CsA and control groups. CsA concentration in the vitreous (ng/ml) was 257.07 ± 117.23, 271.15 ± 98.96, 296.66 ± 86.25, 256.27 ± 99.22, 304.50 ± 88.18, 326.35 ± 105.24, 491.25 ± 119.90 and 589.93 ± 132.55 after 1, 2, 3, 4, 5, 6, 7 and 8 weeks of implantation, respectively. At the end of the study, 21.67 % of mass loss was found. The retina did not show any histological alteration in either group, but a significant reduction in dark-adapted b-wave amplitude was observed in the CsA group, with no changes in a-wave amplitude.
Conclusions
These data show that the PLGA system is safe, but the selective reduction in ERG b-wave amplitude indicates that the PLGA with 350 µg CsA causes retinal function impairment, specifically on the rod postreceptor pathway, 8 weeks after implantation. These ERG changes were not associated with any histological damage as seen at the light microscopy level.
Similar content being viewed by others
References
BenEzra D, Maftzir G (1990) Ocular penetration of cyclosporin A: the rabbit eye. Invest Ophthalmol Vis Sci 31:1362–1366
Nussenblatt RB, Dinning WJ, Fujikawa LS, Chan CC, Palestine AG (1985) Local cyclosporine therapy for experimental autoimmune uveitis in rats. Arch Ophthalmol 103:1559–1562
Alghadyan AA, Peyman GA, Khoobehi B, Liu KR (1988) Liposome-bound cyclosporine: retinal toxicity after intravitreal injection. Int Ophthalmol 12:105–107
Saliba JBFA, Yoshida MI, Vasconcelos WL, Silva-Cunha A, Mansur HS (2008) Development and characterization of an intraocular biodegradable polymer system containing cyclosporine-A for the treatment of posterior uveitis. Mater Res 11:207–211
Saliba JBC-J, Gomes EA, Mansur HS, Silva GR (2011) Development and validation of a high performance liquid chromatographic method for determination of cyclosporine-a from biodegradable intraocular implants. Quim Nova 34:140–144
Yasukawa T, Kimura H, Tabata Y, Ogura Y (2001) Biodegradable scleral plugs for vitreoretinal drug delivery. Adv Drug Deliv Rev 52:25–36
Lee SS, Hughes P, Ross AD, Robinson MR (2010) Biodegradable implants for sustained drug release in the eye. Pharm Res 27:2043–2053
Dong X, Shi W, Yuan G, Xie L, Wang S, Lin P (2006) Intravitreal implantation of the biodegradable cyclosporin A drug delivery system for experimental chronic uveitis. Graefes Arch Clin Exp Ophthalmol 244:492–497
He Y, Wang JC, Liu YL, Ma ZZ, Zhu XA, Zhang Q (2006) Therapeutic and toxicological evaluations of cyclosporine a microspheres as a treatment vehicle for uveitis in rabbits. J Ocul Pharmacol Ther 22:121–131
Gilger BC, Malok E, Stewart T, Horohov D, Ashton P, Smith T, Jaffe GJ, Allen JB (2000) Effect of an intravitreal cyclosporine implant on experimental uveitis in horses. Vet Immunol Immunopathol 76:239–255
Laferty K, Borel JF, Hodgkin P (1983) Cyclosporine-A (CsA); models for the mechanism of action. Transplant Proc 15:2242–2247
Fialho SL, Rego MB, Siqueira RC, Jorge R, Haddad A, Rodrigues AL, Maia-Filho A, Silva-Cunha A (2006) Safety and pharmacokinetics of an intravitreal biodegradable implant of dexamethasone acetate in rabbit eyes. Curr Eye Res 31:525–534
He Y, Liu Y, Wang J, Zhang X, Lu W, Ma Z, Zhu X, Zhang Q (2006) Cyclosporine-loaded microspheres for treatment of uveitis: in vitro characterization and in vivo pharmacokinetic study. Invest Ophthalmol Vis Sci 47:3983–3988
Pearson PA, Jaffe GJ, Martin DF, Cordahi GJ, Grossniklaus H, Schmeisser ET, Ashton P (1996) Evaluation of a delivery system providing long-term release of cyclosporine. Arch Ophthalmol 114:311–317
Schubert G, Bornschein H (1952) Analysis of the human electroretinogram. Ophthalmologica 123:396–413
Hirose T, Wolf E, Hara A (1977) Electrophysiological and psychophysical studies in congenital retinoschisis of X-linked recessive inheritance—Electroretinography-clinical correlations. In: Henkes HE (ed) Documenta ophthalmologica proceedings series—ERG, VER and Psychophysics 14th I. S. C. E. R. G. Symposium, volume 13, Dr W. Junk b.v. Publishers, pp 173–184
Messias A, Ramos Filho JA, Messias K, Almeida FP, Costa RA, Scott IU, Gekeler F, Jorge R (2012) Electroretinographic findings associated with panretinal photocoagulation (PRP) versus PRP plus intravitreal ranibizumab treatment for high-risk proliferative diabetic retinopathy. Doc ophthalmol Adv Ophthalmol 124:225–236
Green DG, Kapousta-Bruneau NV (1999) A dissection of the electroretinogram from the isolated rat retina with microelectrodes and drugs. Vis Neurosci 16:727–741
Acknowledgments
The authors wish to thank CNPq/MCT (Brazil) and Fapemig (Brazil) for financial support. Special thanks are due to Tim Corson, PhD—Assistant Professor from the Eugene and Marilyn Glick Eye Institute (Indianapolis, USA) for reviewing the manuscript.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Statement on the welfare of animals
All animal experiments were conducted according to the Association for Research in Vision and Ophthalmology policy on the Use of Animals in Ophthalmic and Vision Research.
Rights and permissions
About this article
Cite this article
de Almeida, F.P.P., Saliba, J.B., Ribeiro, J.A.S. et al. In vivo release and retinal toxicity of cyclosporine-loaded intravitreal device. Doc Ophthalmol 131, 207–214 (2015). https://doi.org/10.1007/s10633-015-9520-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10633-015-9520-z